drugset / Trial / NCT00027534

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

NCT00027534 ↗

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Vaccines made from a person's white blood cells that have been treated in the laboratory may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have advanced or metastatic cancer.

Timeline

Start
2002-01
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject TRICOM-CEA(6D) Vaccine — Intravitreal